Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
Pfizer and its Competition in 2012
Motley Fool
Thu, 04/12/12 - 11:26 am
Pfizer
bapineuzumab
solanezumab
Eli Lilly
tofacitinib
Vertex Pharmaceuticals
Incyte
Vertex Pharmaceuticals Could See Strong Gains From Incivek
Seeking Alpha
Mon, 04/9/12 - 12:15 pm
Incivek
Vertex Pharmaceuticals
Dendreon
JNJ
hepatitis C
Achillion
4 Biotech Stocks Outperforming Vertex
Seeking Alpha
Mon, 04/9/12 - 12:08 pm
Vertex Pharmaceuticals
Abbott Laboratories
Bristol-Myers Squibb
Gilead
JNJ
ISTA Pharmaceuticals Gets The Bid It Wants
Seeking Alpha
Tue, 03/27/12 - 09:20 am
Vertex Pharmaceuticals
Novartis
ISTA Pharmaceuticals
Allergan
Bausch & Lomb
M&A
4 Compelling Alternatives To Vertex Pharma
Seeking Alpha
Thu, 02/23/12 - 10:42 am
Vertex Pharmaceuticals
Acorda
Aveo Pharmaceutical
Jazz Pharmaceuticals
Momenta
Can Vertex Pharma shares stage a comeback?
Marketwatch
Fri, 02/10/12 - 10:52 am
Vertex Pharmaceuticals
Incivek
hepatitis C
Curing Diseases Makes For a Bad Business Model (Vertex and Hepatitis C)
Motley Fool
Sat, 02/4/12 - 04:37 pm
Vertex Pharmaceuticals
hepatitis C
Incivek
The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
Sat, 02/4/12 - 03:30 pm
Theratechnologies
SeraCare Life Sciences
Gentium
Curis
BioDelivery Sciences
Amarin
Affymetrix
Affymax
Vertex Pharmaceuticals
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
Seeking Alpha
Wed, 02/1/12 - 12:19 pm
Bristol-Myers Squibb
Ariad Pharmaceuticals
Inhibitex
Vertex Pharmaceuticals
Spectrum Pharmaceuticals
MannKind
FDA OKs Vertex Drug For Cystic Fibrosis; $294K/Yr
Pharmalot
Tue, 01/31/12 - 03:07 pm
FDA
cystic fibrosis
Vertex Pharmaceuticals
Kalydeco
3 Biotech Buyout Candidates for 2012
Motley Fool
Tue, 01/31/12 - 08:00 am
Vertex Pharmaceuticals
ONYX Pharmaceuticals
Acorda
Biogen Idec
GSK
Novartis
Bayer
Pfizer
Teva Pharmaceuticals
Merck
JNJ
Vertex Falls as Analyst Cuts Sales Estimates on Hepatitis C Pill
Bloomberg
Mon, 01/30/12 - 12:04 pm
Vertex Pharmaceuticals
hepatitis C
Incivek
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Seeking Alpha
Fri, 01/27/12 - 11:08 am
Alexion
Amgen
Ariad
Biogen Idec
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
Vertex Pharmaceuticals
6 Biotech Plays With High Risk/Reward Potential
Seeking Alpha
Sun, 01/22/12 - 12:20 pm
Vertex Pharmaceuticals
Chelsea Therapeutics
ONYX Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Cell Therapeutics
7 Large-Cap Biotech Equities With Strong Momentum Right Now
Seeking Alpha
Sat, 01/14/12 - 11:32 am
Amgen
Ariad Pharmaceuticals
Biogen
Celgene
Gilead Sciences
Vertex Pharmaceuticals
7 Biotech Stocks Barclays Rates As Outperform
Seeking Alpha
Fri, 01/13/12 - 10:31 am
Celgene
Ziopharm
Jazz Pharmaceuticals
Vertex Pharmaceuticals
Ariad
Biogen Idec
Alexion
Biotech Post-Holiday Regifting
Motley Fool
Wed, 12/28/11 - 06:18 pm
Emergent BioSolutions
Abbott Laboratories
Teva Pharmaceuticals
Immunomedics
UCB Pharmaceuticals
Exelixis
JNJ
Eli Lilly
Vertex Pharmaceuticals
5 High Risk/Reward Biotechs For 2012
Seeking Alpha
Mon, 12/5/11 - 06:13 pm
ONYX Pharmaceuticals
Vertex Pharmaceuticals
Amarin
Chelsea Therapeutics
Cell Therapeutics
7 Black Friday Biotech Bargains
Motley Fool
Sat, 11/26/11 - 10:50 am
Dendreon
Human Genome Sciences
GSK
Avanir
Exelixis
MannKind
Amarin
Vertex Pharmaceuticals
Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis
Yahoo/BusinessWire
Sun, 11/6/11 - 11:59 am
Vertex Pharmaceuticals
JAK3 inhibitors
VX-509
rheumatoid arthritis
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »